Handling Systems from Full-Service Systems Integrator esmo …
WEBAs a full-service systems integrator, esmo semicon offers a full suite of test equipment solutions, including automatic test equipment (ATE) and automated handling solutions, for the international semiconductor test industry.
First-Line Treatment with Atezolizumab Associated with... - ESMO
WEBJul 21, 2023 · The PD-L1 inhibitor atezolizumab has been shown to improve OS versus single-agent chemotherapy in patients with previously treated metastatic NSCLC and as first-line treatment in PD-L1–high NSCLC, but these studies only enrolled patients with good performance status.
esmo semicon manipulators, carts + test floor equipment
WEBesmo design specialists develop individual solutions for the adaptation and integration of test head manipulators and mechanical interfacing systems into test cells for both front- and back-end testing.
Atezo + sacituzumab govitecan show encouraging activity in TNBC
WEBMay 22, 2024 · Interim analysis of the MORPHEUS-panBC trial reported an encouraging activity of atezolizumab plus sacituzumab govitecan in patients with previously untreated PD-L1 positive locally advanced or metastatic triple-negative breast cancer (ESMO Breast Cancer 2024, 181O)
Atezolizumab Improves PFS in Advanced Endometrial Cancer
WEBOct 25, 2023 · Adding atezolizumab to chemotherapy improved progression-free survival (PFS) in a phase 3 trial of patients with advanced, newly diagnosed or recurrent endometrial cancer.
Neoadjuvant Atezolizumab Plus Chemotherapy Is Safe and Has Promis - ESMO
WEBJan 11, 2024 · A combination of neoadjuvant atezolizumab plus chemotherapy led to a major pathologic response (MPR) in 70% and a pathologic complete response (pCR) in 45% of patients with previously untreated resectable gastric and gastro-oesophageal junction cancer included in the phase II PANDA study.
500kg ATE manipulator_esmo Yinglong
WEBKey features. 2 load capacity available: Standard load 500kg (1102 lbs), maximum 600kg (1323 lbs) depending on system configuration. dedicated for IC universal test. field communicators control for smoother operation. electric control Z-axis direction, up and down movement more simple and efficient. optional motorized X-axis direction control.
Atezolizumab plus bevacizumab versus lenvatinib as first-line …
WEBSep 3, 2023 · Similarly, the recently updated guidelines from the European Society of Medical Oncology (ESMO) also recommend ATE/BEV as the first-line therapy, with alternative options being LEN and sorafenib.
Tester-Prober Interfaces: The Move to Direct Probe - esmo AG
WEBAutomatic Test Equipment Replaces Inefficient Manual Positioning. The field of semiconductor automatic test equipment (ATE) has been rich with challenges and opportunities since the first transistors were mass-produced by Texas Instruments in 1954.
Venous thromboembolism in cancer patients: ESMO Clinical …
WEBJan 10, 2023 · With a focus on ease of implementation, this updated European Society for Medical Oncology (ESMO) Clinical Practice Guideline (CPG) summarises recommendations for prevention and treatment of VTE in patients with cancer.